IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GUY R CZAYKOWSKI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1659429223
CMS profile
1207312
Location
DAYTONA BEACH, FL

General Payments · PY2018–2024

$7,380.41

  • Reported across 365 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,190.56

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry FL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,190.56 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $533.00 28
E.R. Squibb & Sons, L.L.C. $194.46 4
Alkermes, Inc. $165.18 6
Janssen Pharmaceuticals, Inc $99.09 4
ITI, Inc. $98.04 5
Otsuka America Pharmaceutical, Inc. $78.31 4
ABBVIE INC. $22.48 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $551.73 38
PY2019 $1,197.90 54
PY2020 $584.36 34
PY2021 $937.24 47
PY2022 $1,269.46 53
PY2023 $1,649.16 87
PY2024 $1,190.56 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.48 03/21/2024 Food and Beverage Undisputed 01/23/2026 1103525274 CMS
Alkermes, Inc. $29.55 02/01/2024 Food and Beverage Undisputed 01/23/2026 1120486197 CMS
Alkermes, Inc. $22.20 07/17/2024 Food and Beverage Undisputed 01/23/2026 1120486199 CMS
Alkermes, Inc. $26.25 08/21/2024 Food and Beverage Undisputed 01/23/2026 1120486201 CMS
Alkermes, Inc. $28.33 09/04/2024 Food and Beverage Undisputed 01/23/2026 1120486203 CMS
Alkermes, Inc. $26.13 10/02/2024 Food and Beverage Undisputed 01/23/2026 1120486205 CMS
Alkermes, Inc. $32.72 10/23/2024 Food and Beverage Undisputed 01/23/2026 1120486207 CMS
E.R. Squibb & Sons, L.L.C. $20.04 09/18/2024 Food and Beverage Undisputed 01/23/2026 1101247098 CMS
E.R. Squibb & Sons, L.L.C. $29.89 10/16/2024 Food and Beverage Undisputed 01/23/2026 1101247126 CMS
E.R. Squibb & Sons, L.L.C. $126.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 1101247128 CMS
E.R. Squibb & Sons, L.L.C. $18.03 12/11/2024 Food and Beverage Undisputed 01/23/2026 1101247118 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.45 01/24/2024 Food and Beverage Undisputed 01/23/2026 1143213006 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.87 04/25/2024 Food and Beverage Undisputed 01/23/2026 1143213009 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.59 05/29/2024 Food and Beverage Undisputed 01/23/2026 1143213013 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.16 08/19/2024 Food and Beverage Undisputed 01/23/2026 1143213017 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.97 12/05/2024 Food and Beverage Undisputed 01/23/2026 1143213021 CMS
Janssen Pharmaceuticals, Inc $26.08 02/08/2024 Food and Beverage Undisputed 01/23/2026 1077957314 CMS
Janssen Pharmaceuticals, Inc $26.37 05/02/2024 Food and Beverage Undisputed 01/23/2026 1077957304 CMS
Janssen Pharmaceuticals, Inc $29.40 06/05/2024 Food and Beverage Undisputed 01/23/2026 1077957152 CMS
Janssen Pharmaceuticals, Inc $17.24 10/30/2024 Food and Beverage Undisputed 01/23/2026 1077957278 CMS
Otsuka America Pharmaceutical, Inc. $24.62 02/29/2024 Food and Beverage Undisputed 01/23/2026 1118881258 CMS
Otsuka America Pharmaceutical, Inc. $19.96 08/28/2024 Food and Beverage Undisputed 01/23/2026 1118881260 CMS
Otsuka America Pharmaceutical, Inc. $14.56 10/30/2024 Food and Beverage Undisputed 01/23/2026 1118881262 CMS
Otsuka America Pharmaceutical, Inc. $19.17 11/20/2024 Food and Beverage Undisputed 01/23/2026 1118881264 CMS
Teva Pharmaceuticals USA, Inc. $19.76 01/10/2024 Food and Beverage Undisputed 01/23/2026 1151483881 CMS
Teva Pharmaceuticals USA, Inc. $6.25 01/30/2024 Food and Beverage Undisputed 01/23/2026 1151483891 CMS
Teva Pharmaceuticals USA, Inc. $8.94 02/06/2024 Food and Beverage Undisputed 01/23/2026 1151483893 CMS
Teva Pharmaceuticals USA, Inc. $20.15 02/06/2024 Food and Beverage Undisputed 01/23/2026 1151483895 CMS
Teva Pharmaceuticals USA, Inc. $25.92 02/21/2024 Food and Beverage Undisputed 01/23/2026 1151483911 CMS
Teva Pharmaceuticals USA, Inc. $15.62 03/06/2024 Food and Beverage Undisputed 01/23/2026 1151483913 CMS
Teva Pharmaceuticals USA, Inc. $16.27 03/13/2024 Food and Beverage Undisputed 01/23/2026 1151483915 CMS
Teva Pharmaceuticals USA, Inc. $2.83 03/14/2024 Food and Beverage Undisputed 01/23/2026 1151483917 CMS
Teva Pharmaceuticals USA, Inc. $5.09 03/14/2024 Food and Beverage Undisputed 01/23/2026 1151483919 CMS
Teva Pharmaceuticals USA, Inc. $19.81 03/27/2024 Food and Beverage Undisputed 01/23/2026 1151483931 CMS
Teva Pharmaceuticals USA, Inc. $29.71 04/03/2024 Food and Beverage Undisputed 01/23/2026 1151483933 CMS
Teva Pharmaceuticals USA, Inc. $16.54 04/10/2024 Food and Beverage Undisputed 01/23/2026 1151483935 CMS
Teva Pharmaceuticals USA, Inc. $6.82 04/16/2024 Food and Beverage Undisputed 01/23/2026 1151483937 CMS
Teva Pharmaceuticals USA, Inc. $22.36 05/09/2024 Food and Beverage Undisputed 01/23/2026 1151483945 CMS
Teva Pharmaceuticals USA, Inc. $18.73 05/10/2024 Food and Beverage Undisputed 01/23/2026 1151483947 CMS
Teva Pharmaceuticals USA, Inc. $21.59 05/22/2024 Food and Beverage Undisputed 01/23/2026 1151483957 CMS
Teva Pharmaceuticals USA, Inc. $23.76 06/13/2024 Food and Beverage Undisputed 01/23/2026 1151483959 CMS
Teva Pharmaceuticals USA, Inc. $22.37 06/20/2024 Food and Beverage Undisputed 01/23/2026 1151483974 CMS
Teva Pharmaceuticals USA, Inc. $120.83 06/20/2024 Food and Beverage Undisputed 01/23/2026 1151483984 CMS
Teva Pharmaceuticals USA, Inc. $15.71 07/10/2024 Food and Beverage Undisputed 01/23/2026 1151483976 CMS
Teva Pharmaceuticals USA, Inc. $18.04 07/24/2024 Food and Beverage Undisputed 01/23/2026 1151483978 CMS
Teva Pharmaceuticals USA, Inc. $15.33 08/14/2024 Food and Beverage Undisputed 01/23/2026 1151483992 CMS
Teva Pharmaceuticals USA, Inc. $7.83 08/20/2024 Food and Beverage Undisputed 01/23/2026 1151483994 CMS
Teva Pharmaceuticals USA, Inc. $18.29 09/11/2024 Food and Beverage Undisputed 01/23/2026 1151484004 CMS
Teva Pharmaceuticals USA, Inc. $6.03 09/17/2024 Food and Beverage Undisputed 01/23/2026 1151484006 CMS
Teva Pharmaceuticals USA, Inc. $4.60 12/04/2024 Food and Beverage Undisputed 01/23/2026 1151484024 CMS
Teva Pharmaceuticals USA, Inc. $3.45 12/18/2024 Food and Beverage Undisputed 01/23/2026 1151484032 CMS
Teva Pharmaceuticals USA, Inc. $20.37 12/18/2024 Food and Beverage Undisputed 01/23/2026 1151484034 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.